P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY

• Jakob Nordberg Nørgaard,
• Kari Lenita Falck Moore,
• Tobias Slørdahl,
• Anders Vik,
• Tor Henrik Anderson Tvedt,
• Fredrik Schjesvold

Affiliations

Jakob Nordberg Nørgaard

1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway

Kari Lenita Falck Moore

1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway

Tobias Slørdahl

4 Department of Hematology, St. Olavs Hospital, Trondheim, Norway

Anders Vik

6 Department of Hematology, University Hospital of North Norway, Tromsø, Norway

Tor Henrik Anderson Tvedt

8 Department of Hematology, Oslo University Hospital, Oslo, Norway

Fredrik Schjesvold

1 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway